Erschienen in:
22.09.2015 | Head and Neck
Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program
verfasst von:
Alexandre Bozec, Karen Benezery, Emmanuel Chamorey, Marc Ettaiche, Clair Vandersteen, Olivier Dassonville, Gilles Poissonnet, Jean-Christophe Riss, Jean-Michel Hannoun-Lévi, Marie-Eve Chand, Axel Leysalle, Esma Saada, Anne Sudaka, Juliette Haudebourg, Christophe Hebert, Marie-Noelle Falewee, François Demard, José Santini, Frédéric Peyrade
Erschienen in:
European Archives of Oto-Rhino-Laryngology
|
Ausgabe 9/2016
Einloggen, um Zugang zu erhalten
Abstract
The objective of the study is to evaluate the nutritional
status and determine its impact on clinical outcomes in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy (ICT)-based larynx preservation program without prophylactic feeding-tube placement. All patients with locally advanced (T3/4, N0-3, M0) hypopharyngeal squamous cell carcinoma, technically suitable for total pharyngolaryngectomy, treated by docetaxel, cisplatin and 5-fluorouracil (TPF)-ICT for larynx preservation at our institution between 2004 and 2013, were included in this retrospective study. Patients’ nutritional status was closely monitored. Enteral nutrition was used if and when a patient was unable to sustain per-oral nutrition and hydration. The impact of nutritional status on clinical outcomes was investigated in univariate and multivariate analysis. A total of 53 patients (42 men and 11 women, mean age = 58.6 ± 8.2 years) were included in this study. Six (11.3 %) patients had lost more than 10 % of their usual body weight before therapy. Compared with patients’ usual weight, the mean maximum patient weight loss during therapeutic management was 8.7 ± 4.5 kg. Enteral nutrition was required in 17 patients (32 %). We found no influence of the tested nutritional status-related factors on response to ICT, toxicity of ICT, overall, cause-specific and recurrence-free survival, and on post-therapeutic swallowing outcome. Maximum weight loss was significantly associated with a higher risk of enteral tube feeding during therapy (p = 0.03) and of complications (grade ≥3, p = 0.006) during RT. Without prophylactic feeding-tube placement, approximately one-third of the patients required enteral nutrition. There was no significant impact of nutritional status on oncologic or functional outcomes.